0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Prostate Cancer

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
News From the Centers for Disease Control and Prevention  | 
Cancer Rate Dips as PSA Tests Drop

JAMA Internal Medicine
Research Letter  | 
Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations
Michael E. Zavaski, MD; Christian P. Meyer, MD; Jesse D. Sammon, DO; et al.
JAMA Oncology
Research Letter  | 
Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States A Nationwide Survey Analysis
Firas Abdollah, MD; Maxine Sun, MPH; Jesse D. Sammon, DO; et al.
JAMA Oncology
Original Investigation  | 
Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both The TRAPEZE Randomized Clinical Trial
Nicholas D. James, PhD, FRCR, FRCP; Sarah J. Pirrie, MSc; Ann M. Pope, PhD; et al.